Drug identification system to be compulsory for non-reimbursable OTCs

Published: 2007-01-04 06:57:00

Updated: 2007-01-04 06:57:00

The Korea Food and Drug Administration said on January 2 that it would revise the current drug identification system, in which manufacturers of over-the-counter (OTC) drugs will be required to indicate their OTC dosage forms by using a company marking plus product marking via company logo or numb...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK